Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
Ducrotte P, Sawant P, Jayanthi V
Published in World Journal of Gastroenterology, Vol. 18 (30), pp. 4012-8
Methodology
Four-week randomised double-blind placebo-controlled trial of Lactobacillus plantarum 299v in adults meeting Rome III criteria for IBS
Key Findings
Abdominal pain and bloating severity and frequency fell significantly more with L. plantarum 299v than placebo, with 78 percent rating the treatment good or excellent.
Conclusions
L. plantarum 299v reduces abdominal pain and bloating in IBS.
Limitations
Four-week duration; single-country recruitment; industry-supported.
Supplements Studied
Abdominal pain and bloating severity and frequency fell significantly more with L. plantarum 299v than placebo, with 78 percent rating the treatment good or excellent.
Outcomes Measured
Abdominal pain and bloating severity and frequency fell significantly more with L. plantarum 299v than placebo, with 78 percent rating the treatment good or excellent.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.